CAPR vs KMDA: stock comparison and AI forecast
Capricor Therapeutics, Inc. (CAPR) and Kamada Ltd (KMDA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CAPR Capricor Therapeutics, Inc.
- Market Cap
- $421M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
KMDA Kamada Ltd
- Market Cap
- $425M
- P/E Ratio
- 11.5x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CAPR and KMDA have similar market capitalizations ($421M and $425M).
- KMDA turns 9.8% of its revenue into net income, against -581.4% for CAPR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CAPR | KMDA |
|---|---|---|
| Market Cap | $421M | $425M |
| P/E Ratio | – | 11.50x |
| P/B Ratio | 1.71x | – |
| EPS | $-2.39 | $0.64 |
| Book Value/Share | $4.24 | – |
| Revenue/Share | – | $5.48 |
| FCF/Share | $-1.98 | – |
Profitability & Margins
| Metric | CAPR | KMDA |
|---|---|---|
| ROE | -52.6% | 11.6% |
| ROA | -35.1% | 8.2% |
| ROIC | -40.2% | – |
| Gross Margin | – | 43.0% |
| Operating Margin | -607.1% | 15.5% |
| Net Margin | -581.4% | 9.8% |
| EBT Margin | -570.6% | 13.3% |
| Tax Rate | 0.0% | 12.7% |
Financial Health
| Metric | CAPR | KMDA |
|---|---|---|
| Current Ratio | 7.35x | – |
| D/E Ratio | 0.50x | – |
| Financial Leverage | 1.50x | 1.41x |
| Interest Coverage | -40.9x | – |
| Working Capital | $209M | – |
Cash Flow
| Metric | CAPR | KMDA |
|---|---|---|
| Operating Cash Flow | -$104M | $43M |
| Free Cash Flow | -$115M | – |
| Capital Spending | -$11M | – |
| OCF Growth YoY | – | -48.2% |
Operational Efficiency
| Metric | CAPR | KMDA |
|---|---|---|
| Asset Turnover | – | 0.84x |
| Inventory Turnover | – | 2.1x |
| Fixed Assets Turnover | – | 7.6x |
| Days Inventory | – | 172 days |
| Payables Period | – | 47 days |
Income Statement
| Metric | CAPR | KMDA |
|---|---|---|
| Total Revenue | – | $316M |
| Operating Income | -$135M | $49M |
| Net Income | -$129M | $31M |
| R&D Expense | $100M | $23M |
| Cost of Goods Sold | – | $180M |
Dividend & Shareholder Information
| Metric | CAPR | KMDA |
|---|---|---|
| Shares Outstanding | 58M | 58M |
| EPS Growth | – | 45.5% |
CAPR vs KMDA: stock comparison and AI forecast
Which is bigger, CAPR or KMDA?
CAPR and KMDA have similar market capitalizations ($421M and $425M).
Which one does Intratio's AI model rank higher, CAPR or KMDA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.